Anticoagulant therapy after acute myocardial infarction. Relation of therapeutic benefit to patient's age, sex, and severity of infarction.
D000367:Age Factors; D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000401:mortality; D002986:Clinical Trials as Topic; D048909:Diabetes Complications; D001728:Dicumarol / Q000627:therapeutic use; D004562:Electrocardiography; D005260:Female; D006333:Heart Failure / Q000150:complications; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D010630:Phenindione / Q000009:adverse effects / Q000627:therapeutic use; D010919:Placebos; D011655:Pulmonary Embolism / Q000401:mortality; D012008:Recurrence; D012737:Sex Factors; D013924:Thrombophlebitis / Q000209:etiology; D013997:Time Factors; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D010919:Placebos; D010630:Phenindione; D014859:Warfarin; D001728:Dicumarol; D006493:Heparin